Skip to main contentSkip to navigation
Sirius Investors

WXXWY Stock: WuXi Biologics (Cayman) Inc. Stock Price, Analysis & Insights

Get live WXXWY stock price $7.49, comprehensive WuXi Biologics (Cayman) Inc. stock analysis, charts, news, and expert forecast. Real-time WXXWY stock data and investment insights.

7.49
1.35%Today
WXXWYWuXi Biologics (Cayman) Inc. • Other OTC • Healthcare
Market Cap
15.44B
Volume
59.24K
52W High
11.21
52W Low
6.02

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

WuXi Biologics (Cayman) Inc. delivers integrated solutions covering the entire lifecycle of biological drug development, from initial discovery to full-scale manufacturing. These services are provided to clients worldwide, with a significant presence...

Company Information

CEO
Zhisheng Chen
Sector
Healthcare
Industry
Biotechnology
Employees
12575

Contact Information

Address
No. 108, Meiliang Road
Country
CN

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 22.0)

Lower volatility stock (Beta: 0.56) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for WuXi Biologics (Cayman) Inc. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for WuXi Biologics (Cayman) Inc.
  • Investors should consider how WuXi Biologics (Cayman) Inc. fits within their overall portfolio allocation

Market Cap

15.44B

P/E Ratio (TTM)

22.04

Beta

0.56

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.